Skip to main content
Brinton Pharma Gets DCGI Nod to Market Favipiravir for Covid-19 Treatment, to be Sold at Rs 59 Per Tablet - News18 24-Jul-2020
Brinton Pharma Gets DCGI Nod to Market Favipiravir for Covid-19 Treatment, to be Sold at Rs 59 Per Tablet - News18
In India, Favipiravir was first approved by the regulatory authorities in June 2020 under emergency use authorisation to treat COVID-19 patients, Brinton Phar.
More...